Aspire Biopharma Holdings, Inc. Liabilities, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $1.69M.
- 2026-03-31: Liabilities, Current $3.15M.
- 2025-12-31: Liabilities, Current $7.59M.
- 2025-09-30: Liabilities, Current $13.86M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.69M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.15M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $7.59M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $13.86M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $10.56M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $9.87M 10-Q/A · filed 2025-08-13 | $8.87M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.69M S-1/A · filed 2026-04-10 | $15.62M 10-K · filed 2025-04-07 |
| 2024-09-30 | $6.57M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.24M 10-Q · filed 2024-08-16 | |
| 2024-03-31 | $2.63M 10-Q · filed 2024-06-05 | |
| 2023-12-31 | $403.33K 10-K · filed 2025-04-07 | |
| 2023-09-30 | $316.32K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $284.36K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $356.42K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $303.32K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $188.71K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $146.47K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $51.76K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $293.70K 10-K · filed 2023-03-21 |